Gastroenterology and Hepatology at David H. Koch Center
1283 York Avenue
9th Floor
New York, NY 10065
New and Existing Patients
Already a patient?
Login or sign-upto Connect Patient Portal to make an appointment
Locations and Appointments
New Patients
About Steven M. Lipkin, MD, PhD
GENETIC TESTING, WELLNESS WHOLE EXOME AND GENOME SEQUENCING, EXECUTIVE MEDICINE, ADULT GENETIC DISEASES INCLUDING LYNCH SYNDROME/HNPCC, FAMILIAL ADENOMATOUS POLYPOSIS, HEREDITARY BREAST AND PANCREATIC CANNCER, LI-FRAUMENI, JUVENILE POLYPOSIS, PEUTZ-JEGHERS SYNDROME AND OTHER DISORDERS
Dr. Lipkin is a board certified Medical Geneticist with a focus on genetic testing for adult and cancer genetic diseases, including the Lynch Syndrome, Familial Adenomatous Polyposis, and Hereditary Pancreatic Cancer among others. He is an authority on cancer and adult genetic syndromes, with a particular emphasis on hereditary Gastrointestinal cancer syndromes. He is the author of MAPP-MMR, a bioinfor...
Board Certifications
- Clinical Genetics and Genomics (MD)
Expertise
- ATM Gene Mutation
- BARD1 Gene mutation
- BRCA1 Gene Mutation
- BRCA2 Gene mutation
- Breast Cancer Genetic Susceptibility
- BRIP1 gene mutation
- Cancer Clinical Trials
- Cancer Genetics
- Cancer Screening
- CDH1 Gene Mutation
- CHEK2 Gene Mutation
- Colon Cancer and Polyps
- Colon Cancer Genetic Testing
- Colon Cancer Screening
- Ehlers-Danlos Syndrome
- Endometrial Cancer Genetic Susceptibility
- Familial Adenomatous Polyposis (FAP)
- Family History of Cancer
- Family History of Colorectal Cancer
- Family History of Esophageal Cancer
- Family History of Gastric Cancer
- Family History of Multiple Myeloma
- Family History of Pancreatic Cancer
- FH: Bowel Obstruction
- Gastrointestinal Cancer
- Gastrointestinal Cancer Prevention
- Genetic Counseling
- Genetic Predisposition to Cancer
- Genetic Predisposition to Ovarian Cancer
- Genetic Screening
- Genetic Susceptibility to Breast Cancer
- Genetic Susceptibility to Cancer
- Genetic Susceptibility to Endometrial Cancer
- Genetic Susceptibility to Ovarian Cancer
- Genetic Testing
- Grail Galleri Cancer Surveillance
- Hemochromatosis
- Hereditary Breast Cancer
- Hereditary Breast-Ovarian Cancer
- Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome
- Hereditary Ovarian Cancer
- Inflammatory Bowel Disease
- Inflammatory Bowel Disease (IBD)
- Inflammatory Bowel Diseases (IBD)
- Intensive Cancer Surveillance
- Juvenile Polyposis Syndrome
- Lynch Syndrome
- Marfan Syndrome
- Molecular Cancer Testing
- MYH-Associated Polyposis (MAP)
- Neurofibromatosis Genetic Testing
- Ovarian Cancer, BRCA1 Positive
- Ovarian Cancer, BRCA2 Positive
- PALB2 Gene Mutation
- Personal History of Multiple Myeloma
- Peutz-Jeghers Syndrome
- PRSS1 (Hereditary Pancreatitis)
- PTEN Gene Mutation
- RAD51C Gene Mutation
- RAD51D Gene Mutation
- Review of Cancer Care
- Screening Computed Tomography For Coronary Artery Disease and Lung Cancer
- Screening For Lung Cancer
- Sessile Serrated Polypsis Syndrome
- Surveillance For Colorectal Cancer
- Thyroid Cancer
- Whole Exome Sequencing
- Whole Genome Sequencing
Education
- Fellowship: Duke University Medical Center, NC
- Medical School: Duke University Medical Center, NC
- Residency: Duke University Medical Center, NC
Languages
- English
Titles & Positions
- Professor of Medicine (Courtesy)
Hospital Affiliations
- NewYork-Presbyterian / Weill Cornell Medical Center
Education
- Residency: Duke University Medical Center, NC
- Medical School: Duke University Medical Center, NC
- Fellowship: Duke University Medical Center, NC
Titles & Positions
- Professor of Medicine (Courtesy)
Board Certifications
- clinical genetics and genomics (md)
Languages Spoken
- english
NYP Articles & Features
Moving the Needle Toward a Vaccine for Cancers Associated with Lynch Syndrome
Advances•October 02, 2023
Research
Future Trends in Cancer Prevention and Interception in Cancer Predisposition Syndromes: Leveraging Insights From High-Risk Populations.
July 31, 2026Caspase 5c amplifies Wnt via APC cleavage to promote intestinal homeostasis.
April 22, 2026Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees.
November 10, 2025